Godavari Biorefineries Ltd has announced that it has been granted a Chinese patent for its innovative anti-cancer molecule, marking a significant step forward in the development of treatments for cancer.
The company disclosed the development through a press release to the stock exchanges on Tuesday, July 22, in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015. The patented molecule represents a breakthrough in the field and is intended for use in cancer treatment, expanding the company’s intellectual property portfolio in the life sciences sector.
Godavari Biorefineries stated that this milestone strengthens its ongoing research initiatives and enhances its position in the global pharmaceutical and biotech space.
Further details about the molecule and its planned development pathway are expected to be shared in subsequent announcements.
